Digital biomarker to guide cancer therapy and predict response duration
Precision oncology has led to approved, molecularly specific, biomarker-defined indications for targeted therapies. With the number of validated drug targets increasing, testing each patient's tumor for all markers related ...
Apr 30, 2021
0
0